Does DURVALUMAB Cause Biliary tract infection? 72 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 72 reports of Biliary tract infection have been filed in association with DURVALUMAB (IMFINZI). This represents 0.4% of all adverse event reports for DURVALUMAB.
72
Reports of Biliary tract infection with DURVALUMAB
0.4%
of all DURVALUMAB reports
2
Deaths
61
Hospitalizations
How Dangerous Is Biliary tract infection From DURVALUMAB?
Of the 72 reports, 2 (2.8%) resulted in death, 61 (84.7%) required hospitalization, and 2 (2.8%) were considered life-threatening.
Is Biliary tract infection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DURVALUMAB. However, 72 reports have been filed with the FAERS database.
What Other Side Effects Does DURVALUMAB Cause?
Death (2,817)
Malignant neoplasm progression (1,330)
Pneumonitis (827)
Radiation pneumonitis (786)
Pyrexia (573)
Diarrhoea (530)
Pneumonia (453)
Dyspnoea (444)
Interstitial lung disease (430)
Off label use (395)
What Other Drugs Cause Biliary tract infection?
PACLITAXEL (105)
GEMCITABINE (92)
TREMELIMUMAB (58)
OXALIPLATIN (39)
FLUOROURACIL (32)
NIVOLUMAB (29)
LEUCOVORIN (24)
IRINOTECAN (23)
ATEZOLIZUMAB (22)
BEVACIZUMAB (19)
Which DURVALUMAB Alternatives Have Lower Biliary tract infection Risk?
DURVALUMAB vs DUTASTERIDE
DURVALUMAB vs DUTASTERIDE\TAMSULOSIN
DURVALUMAB vs DUVELISIB
DURVALUMAB vs DYDROGESTERONE
DURVALUMAB vs EBASTINE